Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Omega Therapeutics Inc
OMGACurrent price
1.07 USD
-0.04 USD (-3.60%)
Last closed
1.14 USD
Company
www.omegatherapeutics.com
ISIN
US68217N1054
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
60 118 952 USD
Yield for 12 month
-42.78 %
1Y
3Y
5Y
10Y
15Y
OMGA
Omega Therapeutics, Inc. operates as a clinical-stage biotechnology company. The company's OMEGA platform enables control of fundamental epigenetic processes to correct the root cause of disease by restoring aberrant gene expression to a range without altering native nucleic acid sequences. It also develops OTX-2002 for hepatocellular carcinoma; OTX-2101 for non-small cell lung cancer; omega epigenomic controllers (OEC) for inflammatory lung diseases, such as neutrophilic asthma, acute respiratory distress syndrome, dermatological, oncology, and rheumatological indications; OEC candidates for idiopathic pulmonary fibrosis; liver regeneration medicines; and OEC candidates for patients with diabetes and other conditions to treat corneal epithelial injury. In addition, the company develops OEC candidates for the treatment of alopecia, a disorder characterized by patches of non-scarring hair loss affecting the scalp and body. Omega Therapeutics, Inc. was incorporated in 2016 and is headquartered in Cambridge, Massachusetts. Address: 20 Acorn Park Drive, Cambridge, MA, United States, 02140
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
11.14 USDP/E ratio
–Dividend Yield
–Current Year
+3 094 000 USD
Last Year
+2 073 000 USD
Current Quarter
+2 134 000 USD
Last Quarter
+2 360 000 USD
Current Year
-3 677 000 USD
Last Year
+2 073 000 USD
Current Quarter
+1 521 000 USD
Last Quarter
+544 000 USD
Key Figures OMGA
1 year
3 years
5 years
10 years
EBITDA
-78 886 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-25.37 %
PEG Ratio
–
Return On Equity TTM
-129.15 %
Wall Street Target Price
11.14 USD
Revenue TTM
6 314 000 USD
Book Value
0.48 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
181.2 %
Dividend Yield
–
Gross Profit TTM
-74 023 000 USD
Earnings per share
-1.42 USD
Diluted Eps TTM
-1.42 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics OMGA
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History OMGA
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation OMGA
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
22.3655
Price Sales TTM
9.5215
Enterprise Value EBITDA
-2.1217
Price Book MRQ
2.2892
Financials OMGA
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators OMGA
For 52 weeks
0.89 USD
6.3 USD
50 Day MA
1.21 USD
Shares Short Prior Month
5 610 085
200 Day MA
2.25 USD
Short Ratio
31.09
Shares Short
6 029 891
Short Percent
31.47 %
BeatStart